2015-07-09T12:57:48Z
2015-07-09T12:57:48Z
2014-11
2015-07-09T12:57:48Z
Since 2004, a total of 131 isolates of Streptococcus pneumoniae multidrug-resistant invasive serotype 8 have been detected in Spain. These isolates showed resistance to erythromycin, clindamycin, tetracycline, and ciprofloxacin. All isolates were obtained from adult patients and shared a common genotype (sequence type [ST]63; penicillin-binding protein 1a [pbp1a], pbp2b, and pbp2x gene profiles; ermB and tetM genes; and a ParC-S79F change). Sixty-eight isolates that required a ciprofloxacin MIC ≥16 μg/mL had additional gyrA gene changes. Serotype 8-ST63 pbp2x sequences were identical with those of antimicrobial drug-susceptible serotype 8-ST53 isolates. Serotype 8-ST63 pbp2b sequences were identical with those of the multidrug-resistant Sweden 15A-ST63 clone. Recombination between the capsular locus and flanking regions of an ST53 isolate (donor) and an ST63 pneumococcus (recipient) generated the novel 15A-ST63 clone. One recombination point was upstream of pbp2x and another was within pbp1a. A serotype 8-ST63 clone was identified as a cause of invasive disease in Spain.
Artículo
Versión publicada
Inglés
Pneumococs; Infeccions per pneumococs; Estreptococs; Resistència als medicaments; Malalties de l'aparell respiratori; Malalties infeccioses; Espanya; Streptococcus pneumonia; Pneumococcal Infections; Streptococcus; Drug resistance; Respiratory organs diseases; Communicable diseases; Spain
Centers for Disease Control and Prevention
Reproducció del document publicat a: http://dx.doi.org/10.3201/eid2011.131215
Emerging Infectious Diseases, 2014, vol. 20, num. 11, p. 1848-1856
http://dx.doi.org/10.3201/eid2011.131215
Domini públic / Public domain
http://creativecommons.org/publicdomain/zero/1.0/